Lenalidomide (Revlimid®) is accepted for use within NHSScotland for treatment of adults with previously treated follicular lymphoma

Approval is for use in combination with rituximab (anti-CD20 antibody) for the treatment of adult patients with previously treated follicular lymphoma (Grade 1 to 3a).

Scottish Medicines Consortium